21
Sep

Is Your Supply Chain at Risk? Find out in our Contract Pharma article.

The “race to the bottom” for cost and the cumulative effect of “lean-out” global supply chains have had an unintended consequence for the safe, reliable supply of product. Third-party management has become a growing and recognized risk. And then there’s fourth- and fifth-party management. They are all-important parts of supply chain challenges in today’s increasingly […]

Read More
12
Sep

Lachman Consultants’ Webinar: Are You Considering Annex 1 Sterile Manufacturing Requirements?

Join us September 28th, 2023, at 10:00 AM EDT for A Lachman Learning Experience. Where are you on your Annex 1 journey? Have you created a measurable plan for progress? Assess your current position and start making plans for the future by attending this highly informative and valuable webinar. Join Lachman Consultants’ Executive Director Keith […]

Read More
01
Sep

Is your company suitably staffed? Our article in Contract Pharma takes this issue head on.

According to reports, the pharmaceutical job market has been expanding exponentially in recent months and is on an upward trajectory for job seekers. Occupational profiles are changing and many existing jobs, as a result of automation, are evolving, while completely new jobs are emerging. In this post-pandemic growth period, pharmaceutical companies are beginning to recognize […]

Read More
10
Aug

Is Your Company “Inspection Ready?” Our article in Contract Pharma will help you be better prepared.

It has been more than a year-and-a-half since the FDA released its publication “An update to the Resiliency Roadmap for FDA Inspections.” Are you among the many companies wanting to stay current and who can benefit from some assistance in creating an executable year-to-year plan to maintain both long and short-term inspection proactivity? If so, […]

Read More
03
Aug

Connect with Lachman Consultants at ISPE Singapore Affiliate Conference & Exhibition August 23 – 25, 2023

Join Lachman Consultant Services, Inc. online and in-person at Suntec Singapore for the 2023 ISPE Singapore Affiliate Conference & Exhibition, August 23rd – 25th. The exhibition showcases the latest technologies and services for pharmaceutical and biomanufacturing. The three-day conference is expected to include more than ninety international exhibitors and sponsors. Lachman Consultants is pleased to […]

Read More
11
Jul

Removing Quality Roadblocks For Cell & Gene Therapies

REMOVING QUALITY ROADBLOCKS FOR CELL & GENE THERAPIES REGISTER HERE Keith Lamb, Executive Director, Lachman Consultant Services, Inc., will be joined by a panel of Cell & Gene Therapy (CGT) industry experts from leading organizations as they discuss the key considerations of successful CGT manufacturing and quality strategies. Roundtable topics will include: • Developing a […]

Read More
09
Jun

Meet Lachman Consultants (Ireland) at Medicines for Europe in Malta June 14 – 16

Join Lachman Consultants (Ireland) in Malta for Medicines for Europe 28th Annual Conference, June 14 – 16. The three-day conference features a series of keynotes and sessions around the actions required to address public health needs and build a healthier Europe. The event will also include a discussion led by Lachman Consultants’ President and CEO, […]

Read More
22
May

Meet Lachman Consultants (Ireland) at the 2023 PDA Good Aseptic Manufacturing Conference

Join Lachman Consultants (Ireland) in Leipzig, Germany for the 2023 Parenteral Drug Association (PDA) Good Aseptic Manufacturing Conference on May 23 – 24, to discuss the implications of the new GMP Annex 1 and share insights to help you prepare. As a Gold Sponsor at this year’s event, Lachman will be represented by: John Darby, […]

Read More
11
May

Lachman Consultant Services, Inc. to Participate at This Year’s FDLI Annual Conference as a Gold Sponsor

Join Lachman Consultants at this year’s FDLI Annual Conference in Washington, DC, May 17 –18, 2023, for a two-day hybrid event that will address complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry. Lachman Consultants will be represented by: Martin Shimer (Executive Director) Rachel Thompson, JD (Senior Director) David Petshaft, […]

Read More
1 2